Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 1. Chemical structures. (A) Heterocyclic isoquinoline, quinazolinones and indole backbones. (B) FDA-approved kinase inhibitors with quinoline (Gefitinib), quinazinolone (Idelalisib) or indole (Midostaurin) scaffolds.
Biomol Ther 2019;27:492~501 https://doi.org/10.4062/biomolther.2018.199
© Biomolecules & Therapeutics